These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 32026360)

  • 1. Naturally Occurring Antibodies to Tau Exists in Human Blood and Are Not Changed in Alzheimer's Disease.
    Yu ZY; Li WW; Yang HM; Mañucat-Tan NB; Wang J; Wang YR; Sun BL; Hu ZC; Zhang LL; Tan L; Deng J; Liu YH
    Neurotox Res; 2020 Apr; 37(4):1029-1035. PubMed ID: 32026360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Naturally Occurring Antibodies to P2RY2 Are Decreased in Alzheimer's Disease.
    Jian JM; Fan DY; Cheng Y; Shen YY; Chen DW; Li HY; Chen Y; Zhang Y; Zeng GH; Tan CR; Liu YH; Wang YJ
    J Alzheimers Dis; 2022; 87(2):711-719. PubMed ID: 35342089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in Plasma Amyloid and Tau in a Longitudinal Study of Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Chen TB; Lai YH; Ke TL; Chen JP; Lee YJ; Lin SY; Lin PC; Wang PN; Cheng IH
    Dement Geriatr Cogn Disord; 2019; 48(3-4):180-195. PubMed ID: 31991443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Naturally Occurring Autoantibodies against Tau Protein Are Reduced in Parkinson's Disease Dementia.
    Kronimus Y; Albus A; Balzer-Geldsetzer M; Straub S; Semler E; Otto M; Klotsche J; Dodel R; ; Mengel D
    PLoS One; 2016; 11(11):e0164953. PubMed ID: 27802290
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma Tau Variants Detected by a Novel Anti-Tau Monoclonal Antibody: A Potential Biomarker for Alzheimer's Disease.
    González A; Guzmán-Martínez L; Maccioni RB
    J Alzheimers Dis; 2020; 77(2):877-883. PubMed ID: 32741827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Nanoplasmonic Biosensor for Ultrasensitive Detection of Alzheimer's Disease Biomarker Using a Chaotropic Agent.
    Kim H; Lee JU; Kim S; Song S; Sim SJ
    ACS Sens; 2019 Mar; 4(3):595-602. PubMed ID: 30747516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naturally occurring autoantibodies against Aβ oligomers exhibited more beneficial effects in the treatment of mouse model of Alzheimer's disease than intravenous immunoglobulin.
    Wang T; Xie XX; Ji M; Wang SW; Zha J; Zhou WW; Yu XL; Wei C; Ma S; Xi ZY; Pang GL; Liu RT
    Neuropharmacology; 2016 Jun; 105():561-576. PubMed ID: 26907803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
    Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Diagnostic Potential of Circulating Autoantibodies to Amyloid-β in Alzheimer's Disease.
    Xu GY; Liu YH; Zeng XQ; Chen DW; Zeng GH; Fan DY; Liu YH; Wang YJ
    J Alzheimers Dis; 2023; 94(2):537-546. PubMed ID: 37334604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Alz-tau Biomarker for Alzheimer's Disease: Study in a Caucasian Population.
    Guzmán-Martínez L; Tapia JP; Farías GA; González A; Estrella M; Maccioni RB
    J Alzheimers Dis; 2019; 67(4):1181-1186. PubMed ID: 30775977
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tau Platelets Correlate with Regional Brain Atrophy in Patients with Alzheimer's Disease.
    Slachevsky A; Guzmán-Martínez L; Delgado C; Reyes P; Farías GA; Muñoz-Neira C; Bravo E; Farías M; Flores P; Garrido C; Becker JT; López OL; Maccioni RB
    J Alzheimers Dis; 2017; 55(4):1595-1603. PubMed ID: 27911301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts.
    Karikari TK; Pascoal TA; Ashton NJ; Janelidze S; Benedet AL; Rodriguez JL; Chamoun M; Savard M; Kang MS; Therriault J; Schöll M; Massarweh G; Soucy JP; Höglund K; Brinkmalm G; Mattsson N; Palmqvist S; Gauthier S; Stomrud E; Zetterberg H; Hansson O; Rosa-Neto P; Blennow K
    Lancet Neurol; 2020 May; 19(5):422-433. PubMed ID: 32333900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decrease in naturally occurring antibodies against epitopes of Alzheimer's disease (AD) risk gene products is associated with cognitive decline in AD.
    Gu D; Wang L; Zhang N; Wang H; Yu X
    J Neuroinflammation; 2023 Mar; 20(1):74. PubMed ID: 36922858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrasensitive assays for detection of plasma tau and phosphorylated tau 181 in Alzheimer's disease: a systematic review and meta-analysis.
    Ding X; Zhang S; Jiang L; Wang L; Li T; Lei P
    Transl Neurodegener; 2021 Mar; 10(1):10. PubMed ID: 33712071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assay of Plasma Phosphorylated Tau Protein (Threonine 181) and Total Tau Protein in Early-Stage Alzheimer's Disease.
    Yang CC; Chiu MJ; Chen TF; Chang HL; Liu BH; Yang SY
    J Alzheimers Dis; 2018; 61(4):1323-1332. PubMed ID: 29376870
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma NT1 Tau is a Specific and Early Marker of Alzheimer's Disease.
    Mengel D; Janelidze S; Glynn RJ; Liu W; Hansson O; Walsh DM
    Ann Neurol; 2020 Nov; 88(5):878-892. PubMed ID: 32829532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of selenium, redox status and their association with plasma amyloid/tau in Alzheimer's disease.
    Krishnan S; Rani P
    Biol Trace Elem Res; 2014 May; 158(2):158-65. PubMed ID: 24682919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma tau, neurofilament light chain and amyloid-β levels and risk of dementia; a population-based cohort study.
    de Wolf F; Ghanbari M; Licher S; McRae-McKee K; Gras L; Weverling GJ; Wermeling P; Sedaghat S; Ikram MK; Waziry R; Koudstaal W; Klap J; Kostense S; Hofman A; Anderson R; Goudsmit J; Ikram MA
    Brain; 2020 Apr; 143(4):1220-1232. PubMed ID: 32206776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood-Based Oligomeric and Other Protein Variant Biomarkers to Facilitate Pre-Symptomatic Diagnosis and Staging of Alzheimer's Disease.
    Williams SM; Schulz P; Rosenberry TL; Caselli RJ; Sierks MR
    J Alzheimers Dis; 2017; 58(1):23-35. PubMed ID: 28372328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Peripheral and central biodistribution of (111)In-labeled anti-beta-amyloid autoantibodies in a transgenic mouse model of Alzheimer's disease.
    Bacher M; Depboylu C; Du Y; Noelker C; Oertel WH; Behr T; Henriksen G; Behe M; Dodel R
    Neurosci Lett; 2009 Jan; 449(3):240-5. PubMed ID: 18786612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.